PGR and breast carcinoma: A recent study by Viale et al. [31] assessed the added benefit of PR for predicting response to chemo-endocrine therapy in ER+ breast cancer, and the investigators did not identify a significant interaction of PR status with chemotherapeutic regimen in predicting disease free survival.